Pericardium
Bacterial Pericarditis
search
Bacterial Pericarditis
, Purulent Pericarditis
See Also
Pericarditis
Tuberculous Pericarditis
Epidemiology
Represent <1% of
Pericarditis
cases in Western Europe and U.S.
Represents <5% of cases worldwide (except for
Tuberculous Pericarditis
)
Non-Tuberculous
Bacteria
l Causes are Uncommon
Most
Pericarditis
cases are instead viral induced and inflammatory (see
Pericarditis Causes
)
Causes
Seeding of
Pericardium
Direct spread from thoracic infection (e.g. empyema)
Endocarditis with paravalvular abscess
Hematogenous spread (
Trauma
, procedures)
Organisms
Coxiella Burnetii
(most common of the nontuberculous purulent causes)
Borelia Burgdorferi (most common of the nontuberculous purulent causes)
Staphylococcus aureus
(high mortality)
Empyema with direct spread or hematogenous spread in children
Streptococcus Pneumoniae
More common prior to current
Immunization
s in U.S.
Haemophilus
Influenza
e
More common prior to current
Immunization
s in U.S.
Mycobacterium tuberculosis
(mortality approaches 85% for untreated cases)
See
Tuberculous Pericarditis
Most common cause in developing countries
Salmonella
Meningococcus
Syphilis
Whipple Disease
Rickettsia
Findings
See
Pericarditis
Ill or septic appearing, febrile patients
Differential Diagnosis
See
Pericarditis Causes
Diagnosis
Pericardiocentesis
for
Gram Stain
and culture
Management
See
Pericarditis
Purulent Bacterial Pericarditis
Typically empiric
Antibiotic
s, then guided by
Pericardiocentesis
fluid culture and sensitivity
First-line
Antibiotic
s
Vancomycin
15-20 mg/kg IV every 8-12 hours AND
Ceftriaxone
2 g IV every 24 hours OR
Cefepime
2 g IV every 12 hours
Alternative regimen
Vancomycin
15-20 mg/kg IV every 8-12 hours AND
Ciprofloxacin
750 mg orally twice daily OR 400 mg IV twice daily
Tuberculous Pericarditis
Most common cause of
Pericarditis
in developing world (esp. with
HIV Infection
)
See
Tuberculous Pericarditis
See
Active Tuberculosis Treatment
Interventions
During
Pericardiocentesis
, irrigation and
Fibrin
olytic agent instillation within
Pericardium
may be considered
Pericardial window may be needed in some cases
Prognosis
Associated with worse prognosis than typical idiopathic or
Viral Pericarditis
References
(2016) Sanford Guide, accessed 4/8/2016
Klasek and Alblaihed (2023) Crit Dec Emerg Med 37(6): 4-11
Pankuweit (2005) Am J Cardiovasc Drugs 5(2): 103-12 [PubMed]
Type your search phrase here